Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents (Q24241119)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents (English)

0 references

0 references

1 reference

1 reference

1 reference

1 reference

Shereen Abdelghaffar

1

0 references

Abdelhamid M Attia

series ordinal

2

0 references

publication date

21 January 2009

0 references

published in

0 references

cites work

Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Safety issues on metformin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

A Coefficient of Agreement for Nominal Scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Metformin in type 1 diabetes: is this a good or bad idea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

The insulin-sparing effect of metformin in insulin-treated diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

A risk-benefit assessment of metformin in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Mechanism by which metformin reduces glucose production in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

The case of the misleading funnel plot

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Metformin, the rebirth of a biguanide: mechanism of action and place in the prevention and treatment of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Metformin monotherapy for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Investigating and Dealing with Publication and Other Biases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Insulin resistance due to hyperglycaemia: an adaptation protecting insulin-sensitive tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: Assessment by the artificial pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006691.PUB2

Effects of puberty and diabetes on metabolism of insulin-sensitive fuels.

21 January 2018

1 reference

12 December 2020

Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?

1 reference

12 December 2020

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

Lactic acidosis in patients with diabetes treated with metformin

1 reference

12 December 2020

WHO Expert Committee on Diabetes Mellitus: second report

1 reference

12 December 2020

Studies on juvenile--type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Metformin and insulin: is there a role for combination therapy?

1 reference

12 December 2020

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research

1 reference

12 December 2020

Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes

1 reference

12 December 2020

10.1002/14651858.CD006691.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4574877

OpenCitations bibliographic resource ID

4574877

1 reference